Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4552920
Max Phase: Preclinical
Molecular Formula: C37H51FO5
Molecular Weight: 594.81
Molecule Type: Unknown
Associated Items:
ID: ALA4552920
Max Phase: Preclinical
Molecular Formula: C37H51FO5
Molecular Weight: 594.81
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](OC(=O)c6ccccc6F)[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C37H51FO5/c1-32(2)16-18-37(31(41)42)19-17-35(6)23(24(37)20-32)12-13-28-34(5)21-26(43-30(40)22-10-8-9-11-25(22)38)29(39)33(3,4)27(34)14-15-36(28,35)7/h8-12,24,26-29,39H,13-21H2,1-7H3,(H,41,42)/t24-,26+,27-,28+,29-,34-,35+,36+,37-/m0/s1
Standard InChI Key: PNDPZRWXKGUQTO-VCIHGHCBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 594.81 | Molecular Weight (Monoisotopic): 594.3721 | AlogP: 8.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.83 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.74 | CX Basic pKa: | CX LogP: 8.16 | CX LogD: 5.56 |
Aromatic Rings: 1 | Heavy Atoms: 43 | QED Weighted: 0.27 | Np Likeness Score: 2.34 |
1. Serbian I, Siewert B, Al-Harrasi A, Csuk R.. (2019) 2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells., 180 [PMID:31330447] [10.1016/j.ejmech.2019.07.049] |
Source(1):